MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
When do Meperidine Hydrochloride Preservative Free patents expire, and when can generic versions of Meperidine Hydrochloride Preservative Free launch?
Meperidine Hydrochloride Preservative Free is a drug marketed by Hospira, Icu Medical Inc, Intl Medication, Specgx Llc, Watson Labs, and West-ward Pharms Int. and is included in six NDAs.
The generic ingredient in MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE is meperidine hydrochloride. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meperidine Hydrochloride Preservative Free
A generic version of MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE was approved as meperidine hydrochloride by HIKMA on January 30th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE?
- What are the global sales for MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE?
- What is Average Wholesale Price for MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE?
Summary for MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE
US Patents: | 0 |
Applicants: | 6 |
NDAs: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 45 |
Patent Applications: | 2,423 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE at DailyMed |